AINIA / Soluciones y servicios / Ingredients and Food / Probiotics
- Ingredients and Food
Probióticos
Design and launch of products that help improve consumer health
Probiotics are defined as live microorganisms which, when ingested in adequate amounts, provide a health benefit to the consumer. Interest in foods and beverages with claims related to digestive and intestinal health has increased in recent years and is expected to continue growing.
Responding to consumer demand leads to the development of new or improved products that incorporate microorganisms with a beneficial effect on health. The challenge is to guarantee their functionality and safety within a short period of time in order to enable new product launches.
At AINIA, we add value
- Design of biotechnological processes to obtain microorganisms of interest.
- Customised microencapsulation processes for the stabilisation and release of probiotics.
- Evaluation of bioaccessibility and bioavailability using proprietary technologies. In vitro dynamic digester and cell models.
- In vitro dynamic digester and cell models.
- Legal advice on the use of health claims.
Probiotics
In the development of probiotic microorganisms, we have our own collection of strains and extensive experience in the development and optimisation of advanced fermentation processes. It is also possible to isolate microorganisms with probiotic potential from different sources and carry out functional screening of their activity.
We complement the development of probiotic microorganisms with adaptation techniques such as microencapsulation, which allow us to protect the base microorganisms against industrial processing conditions and their subsequent gastrointestinal resistance once consumed.
Regarding the scientific demonstration of their health benefit, we have proprietary in vitro technology equipment that allows us to evaluate the gastrointestinal resistance of probiotics, as well as the modulation of the intestinal microbiota. We have our in vitro dynamic digester, the colonic fermentation digester and cell models to evaluate intestinal transport and functionality. In addition, we collaborate with specialised hospitals for the development of clinical trials.
We develop probiotics with market differentiation and proven functionalities, ready to be incorporated into a food matrix.
Would you like to know more?
Leave us your details and we will contact you to answer your questions or continue the conversation.